These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 27086392)
21. Early adoption of buprenorphine in substance abuse treatment centers: data from the private and public sectors. Knudsen HK; Ducharme LJ; Roman PM J Subst Abuse Treat; 2006 Jun; 30(4):363-73. PubMed ID: 16716852 [TBL] [Abstract][Full Text] [Related]
22. SAMHSA outlines how to treat addiction to prescription painkillers and heroin in physicians' offices. Conn Med; 2003 Feb; 67(2):103-4. PubMed ID: 12664838 [No Abstract] [Full Text] [Related]
23. The disparate treatment of medications and opiate pain medications under the law: permitting the proliferation of opiates and limiting access to treatment. Ferrara MM Seton Hall Law Rev; 2012; 42(2):741-67. PubMed ID: 22708140 [No Abstract] [Full Text] [Related]
24. Attending physicians' and residents' attitudes and beliefs about prescribing buprenorphine at an urban teaching hospital. Cunningham CO; Sohler NL; McCoy K; Kunins HV Fam Med; 2006 May; 38(5):336-40. PubMed ID: 16673195 [TBL] [Abstract][Full Text] [Related]
26. The prescribing of buprenorphine by advanced practice addictions nurses. Strobbe S; Hobbins D J Addict Nurs; 2012 Feb; 23(1):82-3. PubMed ID: 22468667 [TBL] [Abstract][Full Text] [Related]
27. Public policy statement on buprenorphine for opiate dependence and withdrawal. J Addict Dis; 2004; 23(4):116-7. PubMed ID: 15534969 [No Abstract] [Full Text] [Related]
28. Comment on "Outcomes of DATA certification trainings for the provision of buprenorphine treatment in the Veterans Health Administration". Small MD Am J Addict; 2009; 18(4):336; author reply 337-8. PubMed ID: 19444740 [No Abstract] [Full Text] [Related]
29. Time to include buprenorphine-naloxone combination in the WHO Model List of Essential Medicines. Balhara YP J Opioid Manag; 2013; 9(4):237. PubMed ID: 24380101 [No Abstract] [Full Text] [Related]
31. Buprenorphine: its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence. Sullivan LE; Fiellin DA Clin Infect Dis; 2005 Sep; 41(6):891-6. PubMed ID: 16107991 [TBL] [Abstract][Full Text] [Related]
32. Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults. Cottrill CB; Matson SC Adolesc Med State Art Rev; 2014 Aug; 25(2):251-65. PubMed ID: 27132312 [No Abstract] [Full Text] [Related]
33. Perioperative implications of buprenorphine maintenance treatment for opioid addiction. Gevirtz C; Frost EA; Bryson EO Int Anesthesiol Clin; 2011; 49(1):147-55. PubMed ID: 21239911 [No Abstract] [Full Text] [Related]
34. Drug addiction: an eclectic view. Freedman AM JAMA; 1966 Sep; 197(11):878-82. PubMed ID: 5952775 [No Abstract] [Full Text] [Related]
35. Patients more likely to engage in treatment at 30 days when given buprenorphine in the ED, referred for follow-up. ED Manag; 2015 Aug; 27(8):92-5. PubMed ID: 26258203 [TBL] [Abstract][Full Text] [Related]
36. Buprenorphine for postoperative pain following general surgery in a buprenorphine-maintained patient. Book SW; Myrick H; Malcolm R; Strain EC Am J Psychiatry; 2007 Jun; 164(6):979. PubMed ID: 17541066 [No Abstract] [Full Text] [Related]
37. Office-based practice and opioid-use disorders. Clark HW N Engl J Med; 2003 Sep; 349(10):928-30. PubMed ID: 12954740 [No Abstract] [Full Text] [Related]
39. Role of buprenorphine in the management of heroin addiction. Sung S; Conry JM Ann Pharmacother; 2006 Mar; 40(3):501-5. PubMed ID: 16434562 [TBL] [Abstract][Full Text] [Related]
40. Opioid addiction treatment argued as 'essential' insurance benefit. Herman B Mod Healthc; 2016 Jan; 46(1):10. PubMed ID: 27086374 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]